Eli Lilly Has Trimmed Its Stake in Biopharma Firm Zymeworks
September 05, 2018 at 13:49 PM EDT
Lilly sold 36,931 shares of the Vancouver-based biopharmaceutical firm over the month of August.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.